Paxlovid Reduces Patient Hospitalization Risk by 5 Times
Decreased COVID-19 Vaccination Rates: A Pediatric Health Risk
Increased Rates of Non-Opioid Prescription Following CDC Guidelines
Global Vaccination Coverage Dropped 5% in 2021
FDA Grants Abbott Permission to Investigate DBS in Managing Depression
Aid Access Discusses Making Abortion Pill Available as Contraception
Depression, Anxiety Prescriptions Soar During Coronavirus Pandemic
CDC Recommends Novavax COVID Vaccine
Verve Doses First Patient with Investigational Gene-Editing Medicine
Orexo Pharmaceuticals Announces Nasal Adrenaline Clinical Development
Decentralization Tools May Improve Cancer Clinical Trial Enrollment
HHS Issues Pharmacies’ Obligation to Ensure Access to Reproductive Care
$354M BARDA Contract for Pharmaceutical Manufacturing Goes Unfulfilled
Psychotropic Medications Linked to an Increased Risk of Parkinson’s
HRA Pharma Submits FDA Application for First OTC Birth Control Pill
Decibel Therapeutics Announces Results of DB-020 Clinical Trial
FDA Expands EUA to Allow Pharmacists to Prescribe Paxlovid
FDA Releases Drug Safety Communication regarding Cancer Drug, Copiktra
FDA Approves New Treatment for Large B-Cell Lymphoma
FDA Approves New Weight Management Drug for Kids over 12
HPV Vaccine Rates Increase among Adolescents